As mutated p53 affects protein homeostasis via the proteasome machinery that can inhibit tumor suppression, these results create opportunities to develop combination therapy using drugs to target mutant p53 with anti-proteasome inhibitors. This evidence concerns the gene TP53 and neoplasm.